Stosowanie suplementów u kobiet ciężarnych w świetle najnowszych rekomendacji Polskiego Towarzystwa Ginekologów i Położników

2021
journal article
review article
6
dc.abstract.enIn July 2020, new recommendations of the Polish Society of Gynecologists and Obstetricians for supplementation during pregnancy have been published. The experts emphasized that that "for pregnant women the main source of vitamins, macro-, and microelements should..." should not be multivitamin supplements, but a balanced and varied diet. However, they highlighted an important role of five active substances that are considered as the elementary components of supplementation during pregnancy, namely: folic acid, iodine, vitamin D, docosahexaenoic acid (DHA), and iron. This work aims to present the most recent recommendations of the Polish Society of Gynecologists and Obstetricians, in particular: the role, indications, contraindications, recommended daily dosage, and benefits of supplementation with the main five mentioned constituents, as well as their food sources, daily requirements in Polish population and possible results of deficiency and excessive intake. Summary of the recommendations is as follows: folic acid should be administered by all women at the reproductive age, in dosage range 400-600 pg. Additionally, higher doses should be considered by women with the risk of folates deficiency and with positive history of neural tube defects. Iodine supplementation is recommended in all pregnant women, in dosage range 150-200 pg. In case of thyroid disease, monitoring of thyroid hormones concentrations, as well as thyroidstimulating hormone (TSH) and thyroid antibodies levels is required. Due to high prevalence of vitamin D deficiency in our population, the experts from Polish Society of Gynecologists and Obstetricians recommend administering vitamin D in dosage range 1500-2000 IU, for all pregnant and lactating women. Doses need to be enlarged to 4000 IU when higher risk of deficiency is suspected, e.g. in women with BMI >30. Docosahexaenoic acid (DHA) should be supplemented by pregnant women in a dose of 200 mg, or higher - if the risk of premature birth occurs or low consumption of marine fish is reported. Iron supplementation, in a dose up to 30 mg, is recommended only for pregnant women with the iron deficiency anemia (Hb <11 g/dL), and with low level of ferritin (<60 pg/L). We believe that supplying the most up-to-date information on the topic of supplementation during pregnancy, would help pharmacists to provide pregnant women with professional advice about safe and effective supplementation, and hence contribute to the improvement of the pharmaceutical care quality in Poland.pl
dc.affiliationWydział Farmaceutyczny : Zakład Bromatologiipl
dc.affiliationSzkoła Doktorska Nauk Medycznych i Nauk o Zdrowiupl
dc.cm.date2021-04-01
dc.cm.id103034
dc.cm.idOmegaUJCM9370a985d5244e88ada7a8a1c0735c6fpl
dc.contributor.authorWiesner, Agnieszka - 441099 pl
dc.contributor.authorPaśko, Paweł - 133102 pl
dc.date.accession2021-02-26pl
dc.date.accessioned2021-04-29T09:32:04Z
dc.date.available2021-04-29T09:32:04Z
dc.date.issued2021pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number1pl
dc.description.physical40-47pl
dc.description.points20
dc.description.versionostateczna wersja wydawcy
dc.description.volume77pl
dc.identifier.doi10.32383/farmpol/133610pl
dc.identifier.eissn2544-8552pl
dc.identifier.issn0014-8261pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/270496
dc.identifier.weblinkhttps://ptfarm.pl/wydawnictwa/czasopisma/farmacja-polska/103/-/28923
dc.languagepolpl
dc.language.containerpolpl
dc.pbn.affiliationDziedzina nauk medycznych i nauk o zdrowiu : nauki farmaceutyczne
dc.relation.uri*
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/legalcode.pl*
dc.share.typeOtwarte czasopismo
dc.subject.ensupplementationpl
dc.subject.enpregnancypl
dc.subject.enfolic acidpl
dc.subject.envitamin Dpl
dc.subject.eniodinepl
dc.subtypeReviewArticlepl
dc.titleStosowanie suplementów u kobiet ciężarnych w świetle najnowszych rekomendacji Polskiego Towarzystwa Ginekologów i Położnikówpl
dc.title.alternativeSupplementation during pregnancy according to the most recent recommendations of the Polish Society of Gynecologists and Obstetricianspl
dc.title.journalFarmacja Polskapl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.abstract.enpl
In July 2020, new recommendations of the Polish Society of Gynecologists and Obstetricians for supplementation during pregnancy have been published. The experts emphasized that that "for pregnant women the main source of vitamins, macro-, and microelements should..." should not be multivitamin supplements, but a balanced and varied diet. However, they highlighted an important role of five active substances that are considered as the elementary components of supplementation during pregnancy, namely: folic acid, iodine, vitamin D, docosahexaenoic acid (DHA), and iron. This work aims to present the most recent recommendations of the Polish Society of Gynecologists and Obstetricians, in particular: the role, indications, contraindications, recommended daily dosage, and benefits of supplementation with the main five mentioned constituents, as well as their food sources, daily requirements in Polish population and possible results of deficiency and excessive intake. Summary of the recommendations is as follows: folic acid should be administered by all women at the reproductive age, in dosage range 400-600 pg. Additionally, higher doses should be considered by women with the risk of folates deficiency and with positive history of neural tube defects. Iodine supplementation is recommended in all pregnant women, in dosage range 150-200 pg. In case of thyroid disease, monitoring of thyroid hormones concentrations, as well as thyroidstimulating hormone (TSH) and thyroid antibodies levels is required. Due to high prevalence of vitamin D deficiency in our population, the experts from Polish Society of Gynecologists and Obstetricians recommend administering vitamin D in dosage range 1500-2000 IU, for all pregnant and lactating women. Doses need to be enlarged to 4000 IU when higher risk of deficiency is suspected, e.g. in women with BMI >30. Docosahexaenoic acid (DHA) should be supplemented by pregnant women in a dose of 200 mg, or higher - if the risk of premature birth occurs or low consumption of marine fish is reported. Iron supplementation, in a dose up to 30 mg, is recommended only for pregnant women with the iron deficiency anemia (Hb <11 g/dL), and with low level of ferritin (<60 pg/L). We believe that supplying the most up-to-date information on the topic of supplementation during pregnancy, would help pharmacists to provide pregnant women with professional advice about safe and effective supplementation, and hence contribute to the improvement of the pharmaceutical care quality in Poland.
dc.affiliationpl
Wydział Farmaceutyczny : Zakład Bromatologii
dc.affiliationpl
Szkoła Doktorska Nauk Medycznych i Nauk o Zdrowiu
dc.cm.date
2021-04-01
dc.cm.id
103034
dc.cm.idOmegapl
UJCM9370a985d5244e88ada7a8a1c0735c6f
dc.contributor.authorpl
Wiesner, Agnieszka - 441099
dc.contributor.authorpl
Paśko, Paweł - 133102
dc.date.accessionpl
2021-02-26
dc.date.accessioned
2021-04-29T09:32:04Z
dc.date.available
2021-04-29T09:32:04Z
dc.date.issuedpl
2021
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
1
dc.description.physicalpl
40-47
dc.description.points
20
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
77
dc.identifier.doipl
10.32383/farmpol/133610
dc.identifier.eissnpl
2544-8552
dc.identifier.issnpl
0014-8261
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/270496
dc.identifier.weblink
https://ptfarm.pl/wydawnictwa/czasopisma/farmacja-polska/103/-/28923
dc.languagepl
pol
dc.language.containerpl
pol
dc.pbn.affiliation
Dziedzina nauk medycznych i nauk o zdrowiu : nauki farmaceutyczne
dc.relation.uri*
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC
dc.rights.uri*
http://creativecommons.org/licenses/by-nc/4.0/legalcode.pl
dc.share.type
Otwarte czasopismo
dc.subject.enpl
supplementation
dc.subject.enpl
pregnancy
dc.subject.enpl
folic acid
dc.subject.enpl
vitamin D
dc.subject.enpl
iodine
dc.subtypepl
ReviewArticle
dc.titlepl
Stosowanie suplementów u kobiet ciężarnych w świetle najnowszych rekomendacji Polskiego Towarzystwa Ginekologów i Położników
dc.title.alternativepl
Supplementation during pregnancy according to the most recent recommendations of the Polish Society of Gynecologists and Obstetricians
dc.title.journalpl
Farmacja Polska
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
411
Views per month
Views per city
Warsaw
92
Wroclaw
36
Krakow
35
Katowice
15
Rzeszów
14
Lodz
13
Poznan
13
Gdansk
12
Bialystok
10
Bydgoszcz
6
Downloads
wiesner_pasko_stosowanie_suplementow_u_kobiet_ciezarnych_2021.pdf
539
wiesner_pasko_stosowanie_suplementow_u_kobiet_ciezarnych_2021.odt
11